TCRF与ETA治疗腺样体肥大患者的效果观察  

Effect Observation of TCRF and ETA in the Treatment of Adenoid Hypertrophy

作　　者：蔡继壹 林炳煌 王少将 孙佳琳 彭凤雪 CAI Ji-yi;LIN Bing-huang;WANG Shao-jiang;SUN Jia-lin;PENG Feng-xue(Department of Ophthalmology,Otorhinolaryngology,Jinnan Branch of Jinjiang City Hospital,Fujian Quanzhou 362000)

机构地区：[1]晋江市医院晋南分院眼耳鼻咽喉科,福建泉州362000

出　　处：《中国医疗器械信息》2024年第22期66-68,共3页China Medical Device Information

摘　　要：目的:探究鼻内镜下低温等离子消融术(TCRF)与鼻内镜下腺样体切除(ETA)治疗腺样体肥大(AH)患者的效果。方法:回顾性收集本院2021年1月~2023年12月60例AH患者,依手术方案不同分两组。以接受TCRF治疗的30例患者列为TCRF组,以接受ETA治疗的30例患者列为ETA组。对比两组手术效果、围术期指标、VAS评分、应激反应状态水平及并发症发生率。结果:对比两组手术优良率无明显差异(P>0.05);对比ETA组,TCRF组操作用时、通气时间、咽痛持续时间更短,术中失血量更低(P<0.05);TCRF组术后1d、2d、3dVAS评分低于ETA组,术后1d血清PCT、Cor、PGF_(2α)低于ETA组(P<0.05);两组术后并发症总发生率无明显差异(P>0.05)。结论:相较于ETA治疗AH患者,经TCRF治疗可进一步提升手术效果,减轻疼痛感,优化围术期指标,提升手术安全性,且对机体造成应激反应更轻微。Objective:To investigate the efficacy of endoscopic low temperature plasma ablation(TCRF)and endoscopic adenoidectomy(ETA)in the treatment of adenoid hypertrophy(AH).Methods:60 AH patients in our hospital from January 2021 to December 2023 were retrospectively collected and divided into 2 groups according to different surgical protocols.30 patients treated with TCRF were classified as TCRF group,and 30 patients treated with ETA were classified as ETA group.The operative effect,perioperative indexes,VAS score,stress response status and complication rate of the two groups were compared.Results:There was no significant difference between the two groups(P>0.05).Compared with ETA group,TCRF group had shorter operation time,ventilation time,duration of pharyngeal pain,and lower intraoperative blood loss(P<0.05).The 1d,2d and 3d VAS scores of TCRF group were lower than those of ETA group,and the serum PCT,Cor and PGF_(2α)of TCRF group were lower than those of ETA group(P<0.05).There was no significant difference in the total incidence of postoperative complications between the two groups(P>0.05).Conclusion:Compared with ETA in the treatment of AH patients,TCRF can further improve the surgical effect,reduce pain,optimize perioperative indexes,improve surgical safety,and cause less stress reaction to the body.

关 键 词：腺样体肥大 低温等离子消融术 VAS 优良率 

分 类 号：R766.9[医药卫生—耳鼻咽喉科]